Successful Treatment of Hepatitis C in a Patient with Advanced AIDS and Decompensated Cirrhosis

AIDS Reader

Volumn 13, Issue 10, 2003, Pages 494-496+500

  Johanson, Frank D ^a   Balliram, Debra B ^b  

^a Central Florida Reception Center   (United States)

^b Broward General Medical Center   (United States)

Author keywords

Cirrhosis; Hepatitis C; HIV AIDS; Interferon, pegylated; Mycobacterium avium complex; Ribavirin

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; AMIKACIN; ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; AZITHROMYCIN; CD4 ANTIGEN; CIPROFLOXACIN; COTRIMOXAZOLE; ETHAMBUTOL; FUROSEMIDE; INTERFERON; LIVER ENZYME; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RECOMBINANT ERYTHROPOIETIN; RIBAVIRIN; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANEMIA; ARTICLE; ASCITES; CASE REPORT; COMORBIDITY; DISEASE COURSE; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LEUKOCYTE COUNT; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FUNCTION TEST; LIVER TOXICITY; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM AVIUM; OPPORTUNISTIC INFECTION; TREATMENT OUTCOME; VIRUS HEPATITIS; VIRUS INFECTION; VIRUS LOAD; CD4 LYMPHOCYTE COUNT; PATHOLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTIVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; HEPATITIS C; HUMANS; INTERFERONS; MALE; RIBAVIRIN; TREATMENT OUTCOME; VIRAL LOAD;

EID: 0242385670     PISSN: 10530894     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Sherman KE. Liver disease and antiretroviral therapy. In: HIV/AIDS Annual Update 2001. Milford, Mass: MediOptions; 2001:103-114.
2. Benhamou Y, Bochet M, Di Martino V, et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology. 1999;30:1054-1058.
3. Greub G, Ledergerber B, Battegay M, et al. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study [erratum appears in Lancet. 2001;357:1536]. Lancet. 2000;356:1800-1805.
4. Greub G, Ledergerber B, Battegay M, et al. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study [erratum appears in Lancet. 2001;357:1536]. Lancet. 2000;356:1800-1805.
5. Sulkowski MS, Thomas DL, Chaisson RE, Moore RD. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. JAMA. 2000;283:74-80.